Related Topics

    Leung: News Releases & Feature Stories

    The Best Match

    A test developed by St. Jude improves the selection process for bone marrow transplants.

    Immune system marker tied to improved bone marrow transplant outcomes

    St. Jude Children’s Research Hospital investigators prove that an immune marker predicts transplant success and improves selection of bone marrow donors (Dr. Wing Leung)

    After the Confetti Falls

    St. Jude research doesn’t stop when treatment ends. Studies conducted by our faculty and staff are uncovering new details about the long-term issues facing childhood cancer survivors.

    Hitting out of the Rough - Brennan Simkins

    St. Jude helps budding golfer Brennan Simkins through his battle with a rare form of acute myeloid leukemia, which required four bone marrow transplants.

    Bone marrow transplant survival more than doubles for young high-risk leukemia patients

    St. Jude Children’s Research Hospital investigators reported markedly improved survival of pediatric patients transplanted for high-risk leukemia regardless of donor; cite treatment advances and better donor selection.

    Miracle in the making

    When doctors gave up hope, Jordyn Boucher’s family found it again at St. Jude.

    Double bubble - Addisyn and Madisyn Million

    Because of a rare disease, the Million sisters hardly knew one another. Now Addisyn and Madisyn are together again.

    Research findings underscore needed action to safeguard lungs of young cancer survivors

    St. Jude Children’s Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.

    Study points to new role for donor natural killer cells

    Powerful but rare immune cells taken from a parent might provide a safe, effective and affordable approach to preventing cancer’s return in young patients with acute myeloid leukemia (AML), according to new St. Jude research.

    St. Jude follows outcomes of stem cell transplant survivors

    Patient care at St. Jude doesn't stop when the child is cured. The end of successful therapy is the start of many years of follow-up care.

    Natural killer cells save a St. Jude child

    St. Jude clinicians used immune system cells called natural killer (NK) cells from a father to save the life of his 3-month-old infant daughter who wasn't expected to survive her battle with acute lymphoblastic leukemia (ALL).

    Improving stem cell transplant success

    St. Jude researchers have shown that it might be possible to significantly improve a commonly accepted technique used to identify the best donors of stem cells.